Related Experiment Video
Updated: Aug 9, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Shared idiotype expression by chronic lymphocytic leukemia and B-cell lymphoma
M Chatterjee1, M Barcos, T Han
1Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263.
Antiidiotype antibodies target unique determinants on B-cell tumors for diagnosis and therapy. While some chronic lymphocytic leukemia cases showed reactivity, specific anti-Id antibodies like B4-1 demonstrated potential for B-cell lymphoma classification.
Area of Science:
- Immunology
- Oncology
- Hematology
Background:
- Antiidiotype (Id) antibodies recognize unique determinants on surface immunoglobulin (Ig) of B-cell tumors.
- These antibodies have applications in the diagnosis and therapy of B-cell lymphoma and leukemia.
Purpose of the Study:
- To evaluate the reactivity of a panel of 29 anti-Id monoclonal antibodies (MoAbs) recognizing shared idiotypes (SIds) on B-cell lymphomas against B-cell leukemias and lymphomas.
- To explore the potential of restricted anti-Id reactivity for understanding B-cell lymphoma etiology and developing targeted therapies.
Main Methods:
- Testing a panel of 29 anti-SId MoAbs for reactivity against a cohort of chronic lymphocytic leukemia (CLL) and B-cell lymphoma cases.
- Analyzing the patterns of reactivity to identify specific anti-Id antibodies with potential diagnostic or therapeutic value.
Main Results:
- Ten of 40 (25%) CLL cases reacted with at least one anti-SId MoAb, with no single MoAb showing broad reactivity.
- Eleven of 31 (36%) B-cell lymphoma cases reacted with anti-SId MoAbs, with one antibody (B4-1) showing reactivity to five cases, all of diffuse histology.
- Restricted reactivity patterns were observed, suggesting potential for subclassifying B-cell lymphomas.
Conclusions:
- Anti-SId MoAbs show variable reactivity with CLL and B-cell lymphomas.
- Specific anti-Id antibodies, like B4-1, may offer insights into the etiology and classification of certain B-cell lymphomas.
- These findings suggest that anti-Id antibodies could potentially reduce the need for individually tailored antibody development for patient treatment.
More Related Videos
12:58Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
Published on: May 10, 2017
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Related Concept Videos
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cells of the Adaptive Immune Response
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...